204 related articles for article (PubMed ID: 1496981)
1. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
2. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
[TBL] [Abstract][Full Text] [Related]
4. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
5. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
6. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
7. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of chromosome 22 deletions in schwannomas.
Bijlsma EK; Brouwer-Mladin R; Bosch DA; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1992 Oct; 5(3):201-5. PubMed ID: 1384671
[TBL] [Abstract][Full Text] [Related]
9. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
10. Ring chromosome 22 and neurofibromatosis.
Tommerup N; Warburg M; Gieselmann V; Hansen BR; Koch J; Petersen GB
Clin Genet; 1992 Oct; 42(4):171-7. PubMed ID: 1424240
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
13. Role of the neurofibromatosis type 2 gene in the development of tumors of the nervous system.
Ruttledge MH; Rouleau GA
Neurosurg Focus; 2005 Nov; 19(5):E6. PubMed ID: 16398470
[TBL] [Abstract][Full Text] [Related]
14. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.
Watkins D; Ruttledge MH; Sarrazin J; Rangaratnam S; Poisson M; Delattre JY; Rouleau GA
Cancer Genet Cytogenet; 1996 Nov; 92(1):73-8. PubMed ID: 8956876
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity for chromosome 22 DNA sequences in human meningioma.
Cogen PH; Daneshvar L; Bowcock AM; Metzger AK; Cavalli-Sforza LL
Cancer Genet Cytogenet; 1991 Jun; 53(2):271-7. PubMed ID: 1676608
[TBL] [Abstract][Full Text] [Related]
18. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.
Ruttledge MH; Narod SA; Dumanski JP; Parry DM; Eldridge R; Wertelecki W; Parboosingh J; Faucher MC; Lenoir GM; Collins VP
Neurology; 1993 Sep; 43(9):1753-60. PubMed ID: 8414026
[TBL] [Abstract][Full Text] [Related]
19. A radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 locus.
Frazer KA; Boehnke M; Budarf ML; Wolff RK; Emanuel BS; Myers RM; Cox DR
Genomics; 1992 Nov; 14(3):574-84. PubMed ID: 1427886
[TBL] [Abstract][Full Text] [Related]
20. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]